Viveve Medical with ticker code (VIVE) have now 1 analysts covering the stock. The analyst consensus points to a rating of ‘Strong_Buy’. The target price ranges between 4 and 4 with the average target price sitting at 4. Given that the stocks previous close was at 0.57 this would imply there is a potential upside of 601.8%. The 50 day MA is 0.73 and the 200 day moving average is 1.76. The market capitalisation for the company is $6m. Find out more information at: http://www.viveve.com
Viveve Medical designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical was founded in 2005 and is headquartered in Englewood, Colorado.